Cargando…
Proteotranscriptomics of ocular adnexal B-cell lymphoma reveals an oncogenic role of alternative splicing and identifies a diagnostic marker
BACKGROUND: Ocular adnexal B-cell lymphoma (OABL) is a rare subtype of non-Hodgkin lymphoma. The molecular characteristics of OABL remain poorly understood. We performed an integrated study to investigate the proteotranscriptome landscape and identify novel molecular characteristics and biomarkers o...
Autores principales: | Shi, Jiahao, Zhu, Tianyu, Lin, Huimin, Liu, Zhen, Zhou, Min, Yu, Ziyao, Zhou, Xiaowen, Song, Xin, Wang, Yefei, Jia, Renbing, Fan, Xianqun, Zhou, Yixiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338531/ https://www.ncbi.nlm.nih.gov/pubmed/35906682 http://dx.doi.org/10.1186/s13046-022-02445-8 |
Ejemplares similares
-
Multi‐omics and case‐control analyses identify immunoglobulin M as a tumour‐derived serum biomarker of ocular adnexal extranodal marginal zone lymphoma
por: Shi, Jiahao, et al.
Publicado: (2023) -
Ocular adnexal lymphoma and infectious agents
por: Pellicelli, Adriano M, et al.
Publicado: (2009) -
Chemotherapy alone is an alternative treatment in treating localized primary ocular adnexal lymphomas
por: Ma, Wei-Li, et al.
Publicado: (2017) -
Ocular adnexal lymphoma in the Northeast Indian population
por: Das, Dipankar, et al.
Publicado: (2008) -
Treatment options for ocular adnexal lymphoma (OAL)
por: Cohen, Victoria Mary Lendrum
Publicado: (2009)